大博集团品牌怎么样 申请店铺

我要投票 大博集团在男科医院行业中的票数:426 更新时间:2025-09-11
大博集团是哪个国家的品牌?「大博集团」是 大博医疗科技股份有限公司 旗下著名品牌。该品牌发源于福建省厦门市,由创始人林 * 雄在2004年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力大博集团品牌出海!将品牌入驻外推网,定制大博集团品牌推广信息,可以显著提高大博集团产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

大博集团怎么样

成立于2004年,以骨科、神经外科、微创外科为主的综合性医疗集团,与世界各地的专家建立良好的合作关系和经验交流


大博简介

大博医疗科技股份有限公司,成立于2004年,坐落于美丽的鹭岛——厦门,是一家以骨科、神经外科、微创外科为主的综合性医疗集团。公司先后通过了FDA、CE、ISO13485、GMP等专业认证,产品品质不断超越国际标准,得到国内外用户的一致认可。

研发制造

紧密结合临床,是大博开展研发工作的基石。经多年的钻研沉淀,与国内北上广等地的知名专家,以及澳大利亚、瑞士等国际专家,皆建立起良好的合作关系,广纳临床专家的实践经验,坚持不懈地进行产品和技术的提升与创新。同时,大博成立了厦门骨科医疗器械工程技术研究中心、与厦门大学联合成立厦大化工——大博医疗外科材料研发中心、同时还与台湾科技大学合办产学研项目,并承接多个科技项目。引进国际加工设备,以高度机械化的生产工艺,依托科学的质量管理体系,精心打造各种医疗产品,涵盖骨科、齿科、微创外科、神经外科、医用电子、医疗设备等。

营销网络

大博在产品、推广、服务等各方面进行创新,在全国多省均设有物流平台,构建便捷的物流网络。与近千家经销商通力合作,不断提高服务效率,及时地为3500余家医院提供优质的服务。同时,大博设立专业的“咨询服务与技术支持”团队,为客户提供医疗器械使用方法及技术要点咨询服务,解决医师在临床上遇到的困难和问题。“高品质,赢天下”。大博放眼全球,实行国际化战略布局,拥有涵盖英语、俄语、拉丁语等多语种的国际营销部门,产品直接出口至澳大利亚、瑞士、俄罗斯、乌克兰等20多个国家和地区。

发展战略

为配合企业前进的步伐,大博制定了四化发展战略:专业化——专攻医疗产品,只做业内前三;多元化——在医疗领域内实现产品多元化,打造综合性医用高值材料供应商;国际化——国际化发展战略,产品研发销售皆面向国际市场;创新化——产品研发、企业发展立足创新,推出创新性医疗产品,坚持以创新驱动发展企业。进行以产品为核心的研发、制造、教育、推广。


Founded in 2004, a comprehensive medical group focusing on orthopedics, neurosurgery and minimally invasive surgery, established a good cooperation relationship and experience exchange with experts from all over the world. Dabo Medical Technology Co., Ltd., founded in 2004, is located in Xiamen, the beautiful island of heron. It is a comprehensive medical group focusing on orthopedics, neurosurgery and minimally invasive surgery. The company has passed FDA, CE, ISO13485, GMP and other professional certification. The product quality continues to exceed international standards, and has been unanimously recognized by users at home and abroad. R & D and manufacturing are closely combined with clinical practice, which is the cornerstone of Dabo's R & D work. After years of research and precipitation, we have established good cooperation with well-known experts in China, Beijing, Shanghai, Guangzhou and other places, as well as international experts in Australia, Switzerland and other places. We have widely accepted the practical experience of clinical experts, and have been unremitting in product and technology upgrading and innovation. At the same time, Dabo has established Xiamen orthopedic medical device engineering technology research center, Xiamen University and Xiamen University to jointly establish Xiamen University chemical - Dabo medical surgical material research and development center. At the same time, Dabo and Taiwan University of science and technology jointly run production, teaching and research projects, and undertake a number of scientific and technological projects. With the introduction of international processing equipment, highly mechanized production process, and relying on scientific quality management system, we have carefully built various medical products, including orthopedics, dentistry, minimally invasive surgery, neurosurgery, medical electronics, medical equipment, etc. The marketing network is innovative in products, promotion, services and other aspects. It has logistics platforms in many provinces across the country to build a convenient logistics network. Cooperate with nearly 1000 distributors to improve service efficiency and provide quality services to more than 3500 hospitals in a timely manner. At the same time, Dabo has set up a professional "consulting service and technical support" team to provide customers with consulting services on the use methods and technical points of medical devices, so as to solve the clinical difficulties and problems encountered by doctors. "High quality, win the world". Dabo has a global perspective and an international strategic layout. It has an international marketing department covering English, Russian, Latin and other languages. Its products are directly exported to more than 20 countries and regions, including Australia, Switzerland, Russia, Ukraine and so on. Development strategy in line with the pace of enterprise progress, Dabo has formulated four development strategies: Specialization - specializing in medical products, only making the top three in the industry; diversification - realizing product diversification in the medical field, creating comprehensive medical high-value material suppliers; internationalization - international development strategy, product R & D and sales are oriented to the international market; innovation - Product R & D Based on innovation, the development of enterprises will launch innovative medical products and adhere to innovation driven development of enterprises. Carry out R & D, manufacturing, education and promotion with products as the core.

本文链接: https://brand.waitui.com/2fe6bfaf5.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

济南森峰激光科技股份有限公司启动上市辅导

36氪获悉,据证监会官网显示,济南森峰激光科技股份有限公司于2025年9月10日正式启动上市辅导,民生证券担任辅导机构。

15分钟前

年内公募参与定增项目超八成实现“正收益”

今年以来,公募基金在定增市场的表现颇为亮眼。随着市场回暖,公募八成以上的定增项目实现了浮盈,部分基金在单个定增标的上的浮盈突破千万元,亦有个股因股价大幅攀升带来可观的浮盈比例。业内人士分析,监管支持、市场实践与投资需求的多重共振,使得战略性新兴产业的重组案例不断涌现,为公募基金进一步挖掘行业整合与困境反转机会提供了新的空间。(证券时报)

15分钟前

多重利好因素共振,脑机接口产业链投资机会凸显

在政策大力支持、海内外技术不断突破的背景下,近年来脑机接口行业应用场景逐步清晰,愈发受到市场关注。Wind数据显示,万得脑机接口概念指数9月10日上涨0.32%,近期上涨趋势明显。指数成份股中,美好医疗大涨6.98%,昆仑万维上涨4.71%,创新医疗、赛诺医疗等跟涨。分析人士认为,脑机接口技术当前已经成为全球各国科技竞争的战略高地之一。神经康复、运动功能重建有望成为首批走向产业化、商业化的侵入式脑机接口应用场景,当前我国脑机接口产业有望迎来黄金发展期。(中证网)

15分钟前

宁德时代宜春锂矿复产计划惊动锂圈,碳酸锂期货大跌

虽然宁德时代宜春枧下窝锂矿尚未正式复产,但其即将复产的消息,扰动着碳酸锂市场,引起了市场广泛关注。期货方面,9月10日,国内碳酸锂主力合约以6.9万元/吨开盘,与6.84万元/吨的跌停价仅一步之遥。随后,虽然价格有所回升,但截至当天收盘,下跌幅度仍达到4.87%。碳酸锂其他合约的价格,也同样大幅下跌。9月10日了解到,为了推进枧下窝锂矿复产工作,宜春时代已经成立了工作专班,专项负责该工作。(证券时报)

15分钟前

中国太保:拟发行155.56亿港元可转债

36氪获悉,中国太保在港交所公告,拟根据一般性授权发行15,556,000,000港元于2030年到期的零息可转换债券。可于条款及条件所载情形下转换为H股。初始转换价为每股H股39.04港元(可予调整)。公司拟将发行债券所得款项净额用于支持保险主业;支持大康养、人工智能+、国际化三大战略实施;及补充营运资金等一般企业用途。

15分钟前

本页详细列出关于大博集团的品牌信息,含品牌所属公司介绍,大博集团所处行业的品牌地位及优势。
咨询